Sharesmagazine
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Share Price   Awards   Market Scan   Videos   Broker Notes   Director Deals   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Indices   Forward Diary   Forex Prices   Shares Magazine   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Comparison Tables   Spread Betting 
You are NOT currently logged in
 
Register now or login to post to this thread.

Optos, European inventor of the year ! (OPTS)     

required field - 08 May 2008 16:25

Just won an award.....very Isable..(if you can put it that way)..another of Robbie Burns clever stock picks....decided myself to join in...not sure how high this could go but looking good at the moment !.

goldfinger - 21 Nov 2012 15:54 - 61 of 85

21 Nov Optos PLC OPTS Canaccord Genuity Buy 177.13 165.00 312.00 312.00 Retains

SP target 312p.

Toya - 21 Nov 2012 15:58 - 62 of 85

They look a little gem Goldfinger!

dreamcatcher - 21 Nov 2012 16:04 - 63 of 85

Good buying, lets go for +10% at close.

dreamcatcher - 21 Nov 2012 16:09 - 64 of 85

Optos sees profits rise as it expands
Wed 21 Nov 2012


LONDON (SHARECAST) - Optos’s full-year results beat consensus estimates, driven by increased sales geographically and helped by the roll-out of its latest Daytona device.

For the full year ended September 30th it delivered pre-tax profits of $23.4m (2011: $22m) on revenues of $193.2m (2011: $143.3m) – excluding an additional $3.2m income from the extension of previously-recognised finance leases. This was ahead of consensus estimates of $22.7m in pre-tax profits and $188m in turnover.

Helped by a growing direct and indirect sales force its two geographic segments both delivered double digit increases, with North American sales growing 26% to $147.8m and International sales growing 85% to $48.6m.

For the next financial year, Chief Executive Officer, Roy Davies stressed: “…our priority will be to execute on Daytona and continue our expansion into the ophthalmology market with the 200Tx device.”

Still, progress has been made. There was $21m in revenues from Daytona, its next generation desktop retinal imaging device, with 329 devices installed this year. However, the timing of manufacturing scale up of Daytona contributed to a fall in gross margin from 64% to 57%. The year also saw accelerated growth in ophthalmology, with over 320 200Tx devices installed globally.

Given that its business model has changed from a pay-per-patient rental model to that where customers now acquire their devices outright or through finance leases it is hardly surprising that this is reflected in the sales mix. Outright sales of devices were $64.2m (2011: $37.6m) and new sales under finance leases of were $64.1m (2011:$37.6m). Revenues from operating leases fell to $52.5m (2011: $81.2m). With more customers entering into service contracts, recurring revenues from service and warranty grew to $15.6m (2011: $4.7m).

The results certainly pleased Panmure Gordon analyst Savvas Neophytou, who has reiterated his ‘buy’ recommendation and 320p price target.

goldfinger - 21 Nov 2012 16:25 - 65 of 85

ROBBIE BURNS Buys in again.


I noticed late yesterday Optos (OPTS) had slipped quite dramatically but what was interesting is firstly they had slipped to an area where support had come in a few times, and secondly a statement was due today.

Given today's statement would have to have been really bad for the shares to fall more and I couldn't see any real bad news in its previous update I took the chance and bought some late on yesterday getting 167.75 and 168.5. They have risen a bit on the statement as I write though not as much as I thought they would after the statement as there still seems a seller about.

The statement was fine and it looks cheap under 190p ish - if its Daytona sales can really get going it could be a future star. I should think at the very least it will hit the 210 area again. There seems to be a seller keeping the price back at the mo, so they may need to clear before any rises.

dreamcatcher - 21 Nov 2012 16:32 - 66 of 85

Wonder if there will be a show of late sells, dropped off after 4pm.

goldfinger - 21 Nov 2012 16:46 - 67 of 85

Yep small caps getting hit of late after a fantastic late summer rally.

Xmas bounce will see that right in about 10 days.

dreamcatcher - 21 Nov 2012 16:54 - 68 of 85

Strange this one - you would of put today down to day traders selling on news but the sp was falling a week or so before the news and on low volume.

goldfinger - 22 Nov 2012 08:02 - 69 of 85

Looking for a positive start.

Robbie Burns followers should be buying
in this morning after his tip
late yesterday at approx 4.15pm.

goldfinger - 22 Nov 2012 09:10 - 70 of 85

Optos PLC (OPTS)Chief Pulse Comment by Roy Davis

But Optos chief executive Roy Davis said the share surge "reflected confidence in the business" after a "very strong second half". more
But Optos chief executive Roy Davis said the share surge "reflected confidence in the business" after a "very strong second half". He added: "I am not surprised by the top line because that was what we were shooting for. But it is ahead of expectations"

http://www.heraldscotland.com/business/company-news/optos-share-boost-as-it-defies-sceptics.19485558

goldfinger - 22 Nov 2012 09:13 - 71 of 85

Julie Simmonds, analyst at Canaccord Genuity wrote in a note for clients: "2012 was focused on commercialising Daytona, 2013 is about expansion into new geographic territories and volume delivery. This should result in continuing revenue growth and improved margins, as Daytona volumes increase and manufacturing efficiencies become a focus."

http://www.heraldscotland.com/business/company-news/optos-share-boost-as-it-defies-sceptics.19485558

goldfinger - 22 Nov 2012 09:30 - 72 of 85

Optos PLC (OPTS)22:53 ET Nov 21, 2012Analyst Comment by Savvas Neophytou at Panmure Gordon

Savvas Neophytou, analyst at Panmure Gordon, said: "Optos should be a core holding to investors looking to have healthcare in their portfolio.". more
This should result in continuing revenue growth and improved margins, as Daytona volumes increase and manufacturing efficiencies become a focus.". Savvas Neophytou, analyst at Panmure Gordon, said: "Optos should be a core holding to investors looking to have healthcare in their portfolio.". Optos was founded in 1992 by director Douglas Anderson after his son's retinal problems went undetected.

dreamcatcher - 22 Nov 2012 13:22 - 73 of 85

Get up there !!!!!!!!!!

goldfinger - 23 Nov 2012 03:25 - 74 of 85

he he. 200p here we come.

goldfinger - 23 Nov 2012 08:08 - 75 of 85

Excelent........

"Mr Davis said Optos has received another 250 orders for Daytona devices that it has yet to ship."

Im targeting that line of resistance
on the chart at 200p and sharpish.


Toya - 27 Nov 2012 10:08 - 76 of 85

Investec cuts target price to 157P from 202P
Investec cuts to sell from hold

I wonder why? I've been tempted by this one but not done anything about it yet

dreamcatcher - 27 Nov 2012 10:14 - 77 of 85

There is talk that the targets are very ambitious and the management have plenty of work to do to meet them. So they could tread water.

dreamcatcher - 27 Nov 2012 10:20 - 78 of 85

They need to install 1,000 to 1,500 Daytona machines to hit targets, so far they are in the region of 329. Also gross profit margin has fallen from 64% to 57% as the company's contract renewal program, gave customers the option of sticking with the existing technology.

dreamcatcher - 27 Nov 2012 10:22 - 79 of 85

Next update will be key

dreamcatcher - 27 Nov 2012 10:25 - 80 of 85

I have averaged down and reduced my holding by a significant amount.
Register now or login to post to this thread.